Location History:
- Heidelberg, DE (1991)
- Eppelheim, DE (2021 - 2023)
Company Filing History:
1 out of 171 
1 out of 1 
1 out of 30 
Years Active: 1991-2023
Title: The Innovative Contributions of Peter Terness in Immunotherapy
Introduction
Peter Terness, a prominent inventor located in Eppelheim, Germany, has made significant strides in the field of immunotherapy. With a total of three patents to his name, Terness is recognized for his groundbreaking work, particularly in the realm of organ transplantation and autoimmune diseases.
Latest Patents
Terness's latest patents showcase his innovative approach to specific immunosuppression in transplantation. One of his notable inventions is related to "MIC therapy for specific immunosuppression in transplantation," which includes pharmaceutical compositions featuring isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs). This invention aims to prevent and/or treat organ or cell graft rejection in human graft recipients. Another significant patent is "Immunosuppressive blood cells and methods of producing the same," which details a method for producing immunosuppressive blood cells. These cells are designed for the treatment of autoimmune diseases, notably multiple sclerosis, organ graft rejection, and graft-versus-host disease.
Career Highlights
Throughout his career, Peter Terness has worked with prestigious organizations, including Fresenius AG and Universitätsklinikum Heidelberg. His contributions in these institutions have been instrumental in developing innovative therapies that address complex medical challenges.
Collaborations
Terness has collaborated with noteworthy colleagues, including Gerhard Opelz and Christian Kleist. Their combined efforts have further advanced research and development in the field of immunosuppression, paving the way for improved therapeutic applications.
Conclusion
Peter Terness stands out as a leading inventor whose novel contributions to immunotherapy have had a profound impact on the medical field. His dedication to developing solutions for organ transplantation and autoimmune diseases showcases the important role of innovation in advancing healthcare. With multiple patents and fruitful collaborations, Terness continues to inspire future developments in this critical area of research.